These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22152226)

  • 1. Biology and signal transduction pathways of the Lymphotoxin-αβ/LTβR system.
    Remouchamps C; Boutaffala L; Ganeff C; Dejardin E
    Cytokine Growth Factor Rev; 2011; 22(5-6):301-10. PubMed ID: 22152226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphotoxin-β receptor activation by lymphotoxin-α(1)β(2) and LIGHT promotes tumor growth in an NFκB-dependent manner.
    Daller B; Müsch W; Röhrl J; Tumanov AV; Nedospasov SA; Männel DN; Schneider-Brachert W; Hehlgans T
    Int J Cancer; 2011 Mar; 128(6):1363-70. PubMed ID: 20473944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphotoxin α induces apoptosis, necroptosis and inflammatory signals with the same potency as tumour necrosis factor.
    Etemadi N; Holien JK; Chau D; Dewson G; Murphy JM; Alexander WS; Parker MW; Silke J; Nachbur U
    FEBS J; 2013 Nov; 280(21):5283-97. PubMed ID: 23815148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease.
    Browning JL
    Immunol Rev; 2008 Jun; 223():202-20. PubMed ID: 18613838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs.
    Wilhelm P; Riminton DS; Ritter U; Lemckert FA; Scheidig C; Hoek R; Sedgwick JD; Körner H
    Eur J Immunol; 2002 Jul; 32(7):1993-2003. PubMed ID: 12115620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function.
    Wang J; Foster A; Chin R; Yu P; Sun Y; Wang Y; Pfeffer K; Fu YX
    Eur J Immunol; 2002 Jul; 32(7):1969-79. PubMed ID: 12115617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells.
    Madge LA; Kluger MS; Orange JS; May MJ
    J Immunol; 2008 Mar; 180(5):3467-77. PubMed ID: 18292573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein.
    Columba-Cabezas S; Griguoli M; Rosicarelli B; Magliozzi R; Ria F; Serafini B; Aloisi F
    J Neuroimmunol; 2006 Oct; 179(1-2):76-86. PubMed ID: 16870269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphotoxin-beta receptor signaling regulates hepatic stellate cell function and wound healing in a murine model of chronic liver injury.
    Ruddell RG; Knight B; Tirnitz-Parker JE; Akhurst B; Summerville L; Subramaniam VN; Olynyk JK; Ramm GA
    Hepatology; 2009 Jan; 49(1):227-39. PubMed ID: 19111021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking lymphotoxin beta receptor signalling exacerbates acute DSS-induced intestinal inflammation--opposite functions for surface lymphotoxin expressed by T and B lymphocytes.
    Jungbeck M; Stopfer P; Bataille F; Nedospasov SA; Männel DN; Hehlgans T
    Mol Immunol; 2008 Jan; 45(1):34-41. PubMed ID: 17590442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transcriptional regulation of TNF/LT locus in immune cells].
    Shebzukhov IuV; Kuprash DV
    Mol Biol (Mosk); 2011; 45(1):56-67. PubMed ID: 21485497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of the alternative NF-κB pathway by lymphotoxin αβ (LTαβ) relies on internalization of LTβ receptor.
    Ganeff C; Remouchamps C; Boutaffala L; Benezech C; Galopin G; Vandepaer S; Bouillenne F; Ormenese S; Chariot A; Schneider P; Caamaño J; Piette J; Dejardin E
    Mol Cell Biol; 2011 Nov; 31(21):4319-34. PubMed ID: 21896778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF and lymphotoxin beta cooperate in the maintenance of secondary lymphoid tissue microarchitecture but not in the development of lymph nodes.
    Kuprash DV; Alimzhanov MB; Tumanov AV; Anderson AO; Pfeffer K; Nedospasov SA
    J Immunol; 1999 Dec; 163(12):6575-80. PubMed ID: 10586051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential activities of secreted lymphotoxin-alpha3 and membrane lymphotoxin-alpha1beta2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling.
    Sacca R; Cuff CA; Lesslauer W; Ruddle NH
    J Immunol; 1998 Jan; 160(1):485-91. PubMed ID: 9552007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct contributions of TNF and LT cytokines to the development of dendritic cells in vitro and their recruitment in vivo.
    Abe K; Yarovinsky FO; Murakami T; Shakhov AN; Tumanov AV; Ito D; Drutskaya LN; Pfeffer K; Kuprash DV; Komschlies KL; Nedospasov SA
    Blood; 2003 Feb; 101(4):1477-83. PubMed ID: 12560241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer.
    Das R; Coupar J; Clavijo PE; Saleh A; Cheng TF; Yang X; Chen J; Van Waes C; Chen Z
    Mol Carcinog; 2019 Mar; 58(3):411-425. PubMed ID: 30488488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development.
    Wolf MJ; Seleznik GM; Zeller N; Heikenwalder M
    Oncogene; 2010 Sep; 29(36):5006-18. PubMed ID: 20603617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lymphotoxin β receptor is a potential therapeutic target in renal inflammation.
    Seleznik G; Seeger H; Bauer J; Fu K; Czerkowicz J; Papandile A; Poreci U; Rabah D; Ranger A; Cohen CD; Lindenmeyer M; Chen J; Edenhofer I; Anders HJ; Lech M; Wüthrich RP; Ruddle NH; Moeller MJ; Kozakowski N; Regele H; Browning JL; Heikenwalder M; Segerer S
    Kidney Int; 2016 Jan; 89(1):113-26. PubMed ID: 26398497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for tumor necrosis factor receptor type 1 in gut-associated lymphoid tissue development: genetic evidence of synergism with lymphotoxin beta.
    Koni PA; Flavell RA
    J Exp Med; 1998 Jun; 187(12):1977-83. PubMed ID: 9625757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: transcriptional control mechanisms in oval cells and hepatoma cell lines.
    Subrata LS; Lowes KN; Olynyk JK; Yeoh GC; Quail EA; Abraham LJ
    Liver Int; 2005 Jun; 25(3):633-46. PubMed ID: 15910501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.